---
$id: https://graph.org.ai/products/commodity/51111651
$type: Product
source: UNSPSC
code: "51111651"
title: "Pirazofurin or pyrazofurin"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pirazofurin or pyrazofurin

**UNSPSC Code**: 51111651
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a pyrimidine antagonist and orotidylate decarboxylase inhibitor with the molecular formula C9H13N3O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4B15044GQZ, chemically known as 1h-pyrazole-5-carboxamide, 4-hydroxy-3-beta-d-ribofuranosyl- but generally known as pirazofurin, which bears US NIH Compound Identifier 5360877. European Medicines Agency schedules Pirazofurin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09897MIG. The term PIRAZOFURIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). PIRAZOFURIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Pirazofurin or pyrazofurin bears US NLM identifiers UMLS ID C0072661 and NCI Concept Code C1208. SMILES: C(C1C(C(C(O1)C2=NNC(=C(N)O)C2=O)O)O)O.

